Recurrent glioblastoma could be effectively treated using pembrolizumab

Written by Ebony Torrington (Future Science Group)

Robert Prins and Timothy Cloughesy, lead authors from University of California (CA, USA) and colleagues have shown for the first time that pembrolizumab can be effective in treating people with recurrent glioblastoma. In the study, people treated with pembrolizumab before surgery lived almost twice as long as the average life expectancy for people with the disease. The study was recently published in Nature Medicine. The investigation assessed 35 people with recurrent and surgically resectable glioblastoma, 16 of whom received pembrolizumab before their surgery took place whilst 19 received pembrolizumab after their surgery. The results of this study showed that people...

To view this content, please register now for access

It's completely free